Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
about
Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of actionRole of hepatectomy for recurrent or initially unresectable hepatocellular carcinoma.Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy.Post-progression survival and progression-free survival in patients with advanced hepatocellular carcinoma treated by sorafenib.Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma.Cisplatin based therapy: the role of the mitogen activated protein kinase signaling pathway.
P2860
Modified cisplatin/interferon α-2b/doxorubicin/5-fluorouracil (PIAF) chemotherapy in patients with no hepatitis or cirrhosis is associated with improved response rate, resectability, and survival of initially unresectable hepatocellular carcinoma
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Modified cisplatin/interferon ...... table hepatocellular carcinoma
@en
Modified cisplatin/interferon ...... able hepatocellular carcinoma.
@nl
type
label
Modified cisplatin/interferon ...... table hepatocellular carcinoma
@en
Modified cisplatin/interferon ...... able hepatocellular carcinoma.
@nl
prefLabel
Modified cisplatin/interferon ...... table hepatocellular carcinoma
@en
Modified cisplatin/interferon ...... able hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Modified cisplatin/interferon ...... table hepatocellular carcinoma
@en
P2093
Ahmed O Kaseb
Giuseppe Zimmitti
Hesham M Hassabo
James L Abbruzzese
Junichi Shindoh
Manal M Hassan
Richard D Lozano
Robert E Roses
Steven A Curley
Thomas A Aloia
P2860
P304
P356
10.1002/CNCR.28209
P407
P577
2013-07-02T00:00:00Z